LAMA + LABA inhaler
Glycopyrronium with formoterol fumarate
Brand names: Bevespi Aerosphere
Adult dose
Dose: 2 inhalations BD
Route: Inhaled
Frequency: BD
Clinical pearls
- COPD where step-up from monotherapy required; not licensed for asthma
Contraindications
- Hypersensitivity
Side effects
- Dry mouth
- Tachycardia
- Hypokalaemia
- UTI
- Tremor
- Hyperglycaemia
Interactions
- β-blockers
- Antimuscarinics
- QT-prolonging drugs
Reference: BNF; NICE NG115; GOLD; https://bnf.nice.org.uk/drugs/glycopyrronium-with-formoterol-fumarate/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024